EDGAR Filing Documents for 0001193125-17-080383

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-17-080383

Filing Date

2017-03-13

Accepted

2017-03-13 16:38:20

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d338489ds3.htm	S-3	311863
2	EX-4.2	d338489dex42.htm	EX-4.2	308340
3	EX-4.4	d338489dex44.htm	EX-4.4	109273
4	EX-4.5	d338489dex45.htm	EX-4.5	110283
5	EX-4.6	d338489dex46.htm	EX-4.6	98590
6	EX-5.1	d338489dex51.htm	EX-5.1	24411
7	EX-12.1	d338489dex121.htm	EX-12.1	21085
8	EX-23.1	d338489dex231.htm	EX-23.1	1480
9	GRAPHIC	g338489g32z95.gif	GRAPHIC	2146
10	GRAPHIC	g338489g34e17.jpg	GRAPHIC	16608
	Complete submission text file	0001193125-17-080383.txt		1012352

Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902

Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700

Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)